Ali Bakhshi

Ali Bakhshi

Nanotechnology, Iran University of Science and Technology, Tehran, Tehrān, Iran
+1
orcid
An ascending cosmic dust

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Cell Biology International
Verified
Journal Article
Open access
Saman SargaziSaman Sargazi
Saman Sargazi
Rabia ArshadRabia Arshad
Rabia Arshad
RGReza Ghamari
Reza Ghamari
Abbas RahdarAbbas Rahdar
Abbas Rahdar
Ali BakhshiAli Bakhshi
Ali Bakhshi
Ana Maria Diez-PascualAna Maria Diez-Pascual
Ana Maria Diez-Pascual
Immune‐mediated diseases (IMDs) are chronic conditions that have an immune‐mediated etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have been shown to connect them. While inflammation is a common occurrence in the body, it may either stimulate a favorable immune response to protect against harmful signals or cause illness by damaging cells and tissues. Nanomedicine has tremendous promise for regulating inflammation and treating IMIDs. Various nanoparticles coated with nanotherapeutics have been recently fabricated for effective targeted delivery to inflammatory tissues. RNA interference (RNAi) offers a tremendous genetic approach, particularly if traditional treatments are ineffective against IMDs. In cells, several signaling pathways can be suppressed by using RNAi, which blocks the expression of particular messenger RNAs. Using this molecular approach, the undesirable effects of anti‐inflammatory medications can be reduced. Still, there are many problems with using short‐interfering RNAs (siRNAs) to treat IMDs, including poor localization of the siRNAs in target tissues, unstable gene expression, and quick removal from the blood. Nanotherapeutics have been widely used in designing siRNA‐based carriers because of the restricted therapy options for IMIDs. In this review, we have discussed recent trends in the fabrication of siRNA nanodelivery systems, including lipid‐based siRNA nanocarriers, liposomes, and cationic lipids, stable nucleic acid‐lipid particles, polymeric‐based siRNA nanocarriers, polyethylenimine (PEI)‐based nanosystems, chitosan‐based nanoformulations, inorganic material‐based siRNA nanocarriers, and hybrid‐based delivery systems. We have also introduced novel siRNA‐based nanocarriers to control IMIDs, such as pulmonary inflammation, psoriasis, inflammatory bowel disease, ulcerative colitis, rheumatoid arthritis, etc. This study will pave the way for new avenues of research into the diagnosis and treatment of IMDs.

11 November 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MPMEHRAB POURMADADI
MEHRAB POURMADADI
PAParisa Abbasi
Parisa Abbasi
MEMohammad Mahdi Eshaghi
Mohammad Mahdi Eshaghi
Ali BakhshiAli Bakhshi
Ali Bakhshi
AMAmanda-Lee Ezra Manicum
Amanda-Lee Ezra Manicum
ADAna M. Díez-Pascual
Ana M. Díez-Pascual

22 August 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
KKKhashayar Khodaverdi
Khashayar Khodaverdi
Ali BakhshiAli Bakhshi
Ali Bakhshi
MMM.R. Mozafari
M.R. Mozafari
SNSeyed Morteza Naghib
Seyed Morteza Naghib

29 June 2024 in Materials Today Sustainability
Verified
Journal Article
Closed access
MKMobin Safarzadeh Khosrowshahi
Mobin Safarzadeh Khosrowshahi
AAAmirhossein Afshari Aghajari
Amirhossein Afshari Aghajari
MRMohammad Rahimi
Mohammad Rahimi
FMFarid Maleki
Farid Maleki
EGElahe Ghiyabi
Elahe Ghiyabi
HMHadi Mohammadi
Hadi Mohammadi

14 March 2025 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
Ali BakhshiAli Bakhshi
Ali Bakhshi
MRMehrdad Roshan
Mehrdad Roshan
MAMohammad Sadegh Asgari
Mohammad Sadegh Asgari
FBFatemeh Bijari
Fatemeh Bijari
Ali MalekiAli Maleki
Ali Maleki

11 January 2022 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
MJMaisam Jalaly
Maisam Jalaly
RHReza Hosseini
Reza Hosseini
Ali BakhshiAli Bakhshi
Ali Bakhshi
MCMorteza Chehelamirani
Morteza Chehelamirani